Variant report
Variant | nsv978562 |
---|---|
Chromosome Location | chr17:15647343-15657695 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:48)
- CpG islands (count:489)
- Chromatin interactive region (count:2)
- LncRNA region (count:6)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:48 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr17:15655194-15655285 | GM13976 | blood: | n/a | n/a |
2 | CTCF | chr17:15653545-15653592 | GM13976 | blood: | n/a | n/a |
3 | CTCF | chr17:15653788-15653894 | LNCaP | prostate: | n/a | n/a |
4 | CTCF | chr17:15655205-15655263 | GM13977 | blood: | n/a | n/a |
5 | CTCF | chr17:15654856-15654909 | GM13976 | blood: | n/a | n/a |
6 | CTCF | chr17:15652603-15652660 | A549 | lung: | n/a | chr17:15652623-15652636 |
7 | EBF1 | chr17:15651996-15652216 | GM12878 | blood: | n/a | n/a |
8 | EBF1 | chr17:15651959-15652279 | GM12878 | blood: | n/a | n/a |
9 | EP300 | chr17:15647365-15648950 | ECC-1 | luminal epithelium: | n/a | n/a |
10 | EP300 | chr17:15648028-15648795 | ECC-1 | luminal epithelium: | n/a | n/a |
11 | ESR1 | chr17:15647567-15648739 | ECC-1 | luminal epithelium: | n/a | n/a |
12 | ESR1 | chr17:15648086-15648695 | ECC-1 | luminal epithelium: | n/a | n/a |
13 | ESR1 | chr17:15648131-15648642 | ECC-1 | luminal epithelium: | n/a | n/a |
14 | ESR1 | chr17:15647592-15647971 | ECC-1 | luminal epithelium: | n/a | n/a |
15 | ESR1 | chr17:15647573-15647954 | ECC-1 | luminal epithelium: | n/a | n/a |
16 | ESR1 | chr17:15648102-15648599 | ECC-1 | luminal epithelium: | n/a | n/a |
17 | ESR1 | chr17:15648110-15648614 | ECC-1 | luminal epithelium: | n/a | n/a |
18 | FOXA2 | chr17:15651919-15652290 | A549 | lung: | n/a | n/a |
19 | FOXM1 | chr17:15648024-15648841 | ECC-1 | luminal epithelium: | n/a | n/a |
20 | FOXM1 | chr17:15647797-15648914 | ECC-1 | luminal epithelium: | n/a | n/a |
21 | MAX | chr17:15647233-15649043 | ECC-1 | luminal epithelium: | n/a | chr17:15648825-15648832 chr17:15648824-15648833 chr17:15648824-15648833 chr17:15648824-15648834 |
22 | MAX | chr17:15647263-15649074 | ECC-1 | luminal epithelium: | n/a | chr17:15648825-15648832 chr17:15648824-15648833 chr17:15648824-15648833 chr17:15648824-15648834 |
23 | NFIC | chr17:15647454-15648844 | ECC-1 | luminal epithelium: | n/a | n/a |
24 | NFIC | chr17:15647517-15648768 | ECC-1 | luminal epithelium: | n/a | n/a |
25 | POLR2A | chr17:15652593-15652715 | A549 | lung: | n/a | n/a |
26 | POLR2A | chr17:15652569-15652725 | A549 | lung: | n/a | n/a |
27 | POLR2A | chr17:15652594-15652680 | A549 | lung: | n/a | n/a |
28 | POLR2A | chr17:15656456-15656607 | A549 | lung: | n/a | n/a |
29 | POLR2A | chr17:15648176-15648555 | ECC-1 | luminal epithelium: | n/a | n/a |
30 | REST | chr17:15653262-15653403 | GM12878 | blood: | n/a | n/a |
31 | SPI1 | chr17:15653736-15653931 | GM12878 | blood: | n/a | n/a |
32 | SPI1 | chr17:15651185-15651720 | GM12878 | blood: | n/a | chr17:15651335-15651344 |
33 | SPI1 | chr17:15651247-15651457 | GM12878 | blood: | n/a | chr17:15651335-15651344 |
34 | SPI1 | chr17:15651199-15651481 | GM12878 | blood: | n/a | chr17:15651335-15651344 |
35 | SPI1 | chr17:15651237-15651432 | GM12891 | blood: | n/a | chr17:15651335-15651344 |
36 | SRF | chr17:15647440-15647965 | ECC-1 | luminal epithelium: | n/a | n/a |
37 | TCF12 | chr17:15647945-15649014 | ECC-1 | luminal epithelium: | n/a | chr17:15648420-15648430 chr17:15648424-15648431 |
38 | TCF12 | chr17:15647440-15648865 | ECC-1 | luminal epithelium: | n/a | chr17:15648420-15648430 chr17:15648424-15648431 |
39 | TEAD4 | chr17:15648072-15648778 | ECC-1 | luminal epithelium: | n/a | n/a |
40 | TEAD4 | chr17:15647348-15648816 | ECC-1 | luminal epithelium: | n/a | n/a |
41 | USF1 | chr17:15653388-15653705 | A549 | lung: | n/a | chr17:15653472-15653483 |
42 | USF1 | chr17:15653421-15653756 | A549 | lung: | n/a | chr17:15653472-15653483 |
43 | USF1 | chr17:15653438-15653619 | A549 | lung: | n/a | chr17:15653472-15653483 |
44 | USF1 | chr17:15653249-15653481 | GM12878 | blood: | n/a | n/a |
45 | USF1 | chr17:15653412-15653567 | HepG2 | liver: | n/a | chr17:15653472-15653483 |
46 | USF1 | chr17:15653350-15653615 | HepG2 | liver: | n/a | chr17:15653472-15653483 |
47 | ZBTB7A | chr17:15648021-15648780 | ECC-1 | luminal epithelium: | n/a | n/a |
48 | ZBTB7A | chr17:15648106-15648719 | ECC-1 | luminal epithelium: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr17:15650385-15650435 | HCPEpiC | choroid plexus: | n/a |
2 | chr17:15650385-15650435 | HCPEpiC | choroid plexus: | n/a |
3 | chr17:15652854-15652904 | T-47D | breast: | n/a |
4 | chr17:15650385-15650435 | HNPCEpiC | eye: | n/a |
5 | chr17:15652854-15652904 | HepG2 | liver: | n/a |
6 | chr17:15652329-15652379 | SAEC | small airway: | n/a |
7 | chr17:15650385-15650435 | NB4 | blood: | n/a |
8 | chr17:15652329-15652379 | HUVEC | blood vessel: | n/a |
9 | chr17:15653096-15653146 | SK-N-SH_RA | brain: | n/a |
10 | chr17:15652329-15652379 | HMEC | breast: | n/a |
11 | chr17:15652715-15652765 | HEK293 | kidney: | embryo |
12 | chr17:15653096-15653146 | Hepatocyte | liver: | n/a |
13 | chr17:15653473-15653523 | HepG2 | liver: | n/a |
14 | chr17:15652329-15652379 | HEEpiC | esophagus: | n/a |
15 | chr17:15652854-15652904 | GM06990 | blood: | n/a |
16 | chr17:15652715-15652765 | HPAEpiC | pulmonary alveolar: | n/a |
17 | chr17:15653548-15653598 | SK-N-SH | brain: | n/a |
18 | chr17:15653096-15653146 | Jurkat | blood: | n/a |
19 | chr17:15650385-15650435 | HCM | heart: | n/a |
20 | chr17:15652329-15652379 | GM19239 | blood: | n/a |
21 | chr17:15653473-15653523 | SAEC | small airway: | n/a |
22 | chr17:15650385-15650435 | ECC-1 | luminal epithelium: | n/a |
23 | chr17:15650385-15650435 | HIPEpiC | eye: | n/a |
24 | chr17:15653473-15653523 | GM06990 | blood: | n/a |
25 | chr17:15652854-15652904 | MCF10A-Er-Src | breast: | n/a |
26 | chr17:15650385-15650435 | HRE | kidney: | n/a |
27 | chr17:15653548-15653598 | T-47D | breast: | n/a |
28 | chr17:15653096-15653146 | GM12892 | blood: | n/a |
29 | chr17:15652715-15652765 | NH-A | brain: | n/a |
30 | chr17:15650385-15650435 | T-47D | breast: | n/a |
31 | chr17:15653473-15653523 | NH-A | brain: | n/a |
32 | chr17:15653096-15653146 | HNPCEpiC | eye: | n/a |
33 | chr17:15652329-15652379 | GM12892 | blood: | n/a |
34 | chr17:15653473-15653523 | AG10803 | skin: | n/a |
35 | chr17:15653473-15653523 | H1-hESC | embryonic stem cell: | embryo |
36 | chr17:15652854-15652904 | HRPEpiC | eye: | n/a |
37 | chr17:15655637-15655687 | HEK293 | kidney: | embryo |
38 | chr17:15653473-15653523 | SK-N-SH | brain: | n/a |
39 | chr17:15653548-15653598 | SK-N-MC | brain: | n/a |
40 | chr17:15652715-15652765 | GM12891 | blood: | n/a |
41 | chr17:15652715-15652765 | HCPEpiC | choroid plexus: | n/a |
42 | chr17:15653096-15653146 | HepG2 | liver: | n/a |
43 | chr17:15652715-15652765 | AG04449 | skin: | fetal |
44 | chr17:15653473-15653523 | HCF | heart: | n/a |
45 | chr17:15655637-15655687 | HRPEpiC | eye: | n/a |
46 | chr17:15655637-15655687 | Jurkat | blood: | n/a |
47 | chr17:15652329-15652379 | HCPEpiC | choroid plexus: | n/a |
48 | chr17:15655637-15655687 | AG04449 | skin: | fetal |
49 | chr17:15653096-15653146 | NHDF-neo | bronchial: | n/a |
50 | chr17:15653548-15653598 | HEK293 | kidney: | embryo |
(count:2 , 50 per page) page:
1
(count:6 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-TRIM16-2 | chr17:15652075-15652506 | ENSG00000233002.2 |
2 | lnc-TRIM16-1 | chr17:15649993-15650081 | NONHSAT145863 |
3 | lnc-TRIM16-1 | chr17:15652017-15652629 | NONHSAT145866 |
4 | lnc-TRIM16-1 | chr17:15643410-15648034 | NONHSAT145863 |
5 | lnc-TRIM16-6 | chr17:15650705-15650937 | NONHSAT145865 |
6 | lnc-TRIM16-6 | chr17:15650514-15650937 | ucscGeneNc_uc010cow_1 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000233002 | TF binding region |
ENSG00000267227 | TF binding region |
ENSG00000233002 | CpG island |
ENSG00000267227 | CpG island |
ENSG00000267227 | chromatin interactions |
ENSG00000233002 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs558308845 | chr17:15647347-15647348 | Weak transcription Enhancers | TF binding regionChromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs376367291 | chr17:15647351-15647352 | Weak transcription Enhancers | TF binding regionChromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs557992815 | chr17:15647366-15647367 | Weak transcription Enhancers | TF binding regionChromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs114680808 | chr17:15647371-15647372 | Weak transcription Enhancers | TF binding regionChromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs115703228 | chr17:15647397-15647398 | Weak transcription Enhancers | TF binding regionChromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs191352538 | chr17:15647466-15647467 | Enhancers Weak transcription | TF binding regionChromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs537223503 | chr17:15647481-15647482 | Enhancers Weak transcription | TF binding regionChromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs538353175 | chr17:15647482-15647483 | Enhancers Weak transcription | TF binding regionChromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs558191332 | chr17:15647545-15647546 | Enhancers Weak transcription | TF binding regionChromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs147214687 | chr17:15647584-15647585 | Enhancers Weak transcription | TF binding regionChromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs2240593 | chr17:15647723-15647724 | Enhancers Bivalent Enhancer Genic enhancers | TF binding regionChromatin interactive regionlncRNA | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs554996088 | chr17:15647736-15647737 | Enhancers Bivalent Enhancer Genic enhancers | TF binding regionChromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs183057951 | chr17:15647751-15647752 | Enhancers Bivalent Enhancer Genic enhancers | TF binding regionChromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs543496478 | chr17:15647775-15647776 | Enhancers Bivalent Enhancer Genic enhancers | TF binding regionChromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs557327185 | chr17:15647829-15647830 | Enhancers Genic enhancers | TF binding regionChromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs577267622 | chr17:15647882-15647883 | Enhancers Genic enhancers | TF binding regionChromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs1057430 | chr17:15647895-15647896 | Enhancers Genic enhancers | TF binding regionChromatin interactive regionlncRNA | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs185965003 | chr17:15647912-15647913 | Enhancers Genic enhancers | TF binding regionChromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs527511907 | chr17:15647987-15647988 | Enhancers Genic enhancers | TF binding regionChromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs200656446 | chr17:15647999-15648000 | Enhancers Genic enhancers | TF binding regionChromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs555792699 | chr17:15648007-15648008 | Enhancers | TF binding regionChromatin interactive regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs541205084 | chr17:15648050-15648051 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs572028886 | chr17:15648061-15648062 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs189720562 | chr17:15648092-15648093 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs140534065 | chr17:15648102-15648103 | Enhancers | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs541067755 | chr17:15648310-15648311 | Enhancers Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs368174477 | chr17:15648311-15648312 | Enhancers Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs564369707 | chr17:15648318-15648319 | Enhancers Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs533293515 | chr17:15648329-15648330 | Enhancers Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs373005186 | chr17:15648366-15648367 | Enhancers Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs531948989 | chr17:15648443-15648444 | Enhancers Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs551878165 | chr17:15648467-15648468 | Enhancers Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs565419854 | chr17:15648472-15648473 | Enhancers Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs534943094 | chr17:15648476-15648477 | Enhancers Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs34379438 | chr17:15648493-15648494 | Enhancers Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs548758105 | chr17:15648497-15648498 | Enhancers Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs568513939 | chr17:15648498-15648499 | Enhancers Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs544223096 | chr17:15648534-15648535 | Enhancers Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs376563151 | chr17:15648540-15648541 | Enhancers Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs543237517 | chr17:15648624-15648625 | Enhancers Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs537758032 | chr17:15648627-15648628 | Enhancers Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs183092327 | chr17:15648638-15648639 | Enhancers Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs577330924 | chr17:15648665-15648666 | Enhancers Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs539822375 | chr17:15648677-15648678 | Enhancers Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs187726430 | chr17:15648687-15648688 | Enhancers Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs144404392 | chr17:15648806-15648807 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs144755562 | chr17:15648821-15648822 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs370620095 | chr17:15648851-15648852 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs192691005 | chr17:15648902-15648903 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs62072383 | chr17:15648914-15648915 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 17603634 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Wilms tumour | 21544195 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Chordoma | 21602918 | CNVD |
Miller-Dieker syndrome | 22283845 | CNVD |
Non-syndromic sensorineural hearing loss | 17457615 | CNVD |
Cancer | 22429812 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Breast cancer | 22028636 | CNVD |
Breast cancer | 20837533 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
colon cancer | 17210682 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Chronic lymphocytic leukemia | 17971485 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 16461572 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Breast cancer | 17133270 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Moyamoya disease | 22323933 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Colorectal cancer | 21645411 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
HIV/AIDS | 17953491 | CNVD |
HIV/AIDS | 20877625 | CNVD |
Immune disease | 21076436 | CNVD |
Rheumatoid arthritis | 17953491 | CNVD |
Type 1 diabetes | 17953491 | CNVD |
HIV/AIDS | 15637236 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Neurofibromatosis | 18196300 | CNVD |
Adenoid cystic carcinoma | 18332873 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21509527 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Autism | 17322880 | CNVD |
Hereditary neuropathy with liability to pressure palsy | 19521722 | CNVD |
Schizophrenia | 19571808 | CNVD |
Schizophrenia | 19955444 | CNVD |
Charcot-marie-tooth disease | 18787571 | CNVD |
Breast cancer | 20409316 | CNVD |
Autism | 18414403 | CNVD |
Breast cancer | 17001317 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Peripheral neuropathy | 21193943 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 22958593 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Charcot-marie-tooth disease | 16463004 | CNVD |
Osteosarcoma | 22292074 | CNVD |
Charcot | 16760730 | CNVD |
Mental retardation | 17901693 | CNVD |
ovarian endometriomas | 16273235 | CNVD |
Breast cancer | 21858162 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17142309 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Autism | 22102821 | CNVD |
Gastric cancer | 18160780 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:15637400-15647400 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr17:15646000-15647600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr17:15646000-15647600 | Weak transcription | Lung | lung |
4 | chr17:15646400-15648400 | Enhancers | Placenta | Placenta |
5 | chr17:15647400-15648800 | Enhancers | Ovary | ovary |
6 | chr17:15647400-15649000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
7 | chr17:15647400-15649000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
8 | chr17:15647600-15647800 | Bivalent Enhancer | IMR90 fetal lung fibroblasts Cell Line | lung |
9 | chr17:15647600-15648000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
10 | chr17:15647600-15648000 | Genic enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr17:15647600-15648400 | Enhancers | Fetal Muscle Leg | muscle |
12 | chr17:15647600-15648400 | Enhancers | Lung | lung |
13 | chr17:15647800-15649000 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
14 | chr17:15648000-15648400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
15 | chr17:15648000-15648600 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
16 | chr17:15648000-15648800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
17 | chr17:15648200-15648800 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
18 | chr17:15648200-15648800 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
19 | chr17:15648200-15649000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
20 | chr17:15648800-15652800 | Weak transcription | Ovary | ovary |
21 | chr17:15651400-15651800 | Enhancers | Primary monocytes fromperipheralblood | blood |
22 | chr17:15651400-15651800 | Enhancers | Monocytes-CD14+_RO01746 | blood |
23 | chr17:15652600-15653000 | Bivalent Enhancer | Monocytes-CD14+_RO01746 | blood |
24 | chr17:15652800-15653000 | Bivalent Enhancer | Foreskin Keratinocyte Primary Cells skin03 | Skin |
25 | chr17:15652800-15653000 | Flanking Active TSS | Ovary | ovary |
26 | chr17:15652800-15653000 | Flanking Active TSS | Psoas Muscle | Psoas |
27 | chr17:15652800-15653200 | Enhancers | Placenta Amnion | Placenta Amnion |
28 | chr17:15652800-15653400 | Active TSS | Right Ventricle | heart |
29 | chr17:15653000-15654000 | Active TSS | Ovary | ovary |